Cargando…

Neuroendocrine prostate cancer treated with multimodal examination and therapy: A case report

Neuroendocrine prostate cancer (NEPC) is rare, with short overall survival, and no established standard therapy. Therefore, the management of NEPC is often challenging. We report a case of a 63-year-old male diagnosed with NEPC and treated with multimodal examinations and therapies. Chemotherapy of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hara, Midori, Kira, Satoru, Kamiyama, Manabu, Ihara, Tatsuya, Sato, Takeshi, Mitsui, Takahiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284398/ https://www.ncbi.nlm.nih.gov/pubmed/35846514 http://dx.doi.org/10.1016/j.eucr.2022.102158

Ejemplares similares

Successful Radiotherapy for Advanced Small Cell Carcinoma of the Prostate with Syndrome of Inappropriate Secretion of Antidiuretic Hormone
por: Fukasawa, Masanari, et al.
Publicado: (2017)

A case of urethral metastasis of castration-resistant prostate cancer successfully cured with CyberKnife radiosurgery
por: Kasai, Yoshifumi, et al.
Publicado: (2020)

Metastatic rectal neuroendocrine tumor to kidney, pancreas, and bone following renal tumor resected with robot-assisted laparoscopic partial nephrectomy
por: Kusuda, Mayuko, et al.
Publicado: (2023)

A case of subcutaneous leiomyosarcoma of the scrotum presenting as a slowly growing mass in a 36-year-old male: A case report and literature review
por: Matsuda-Mitake, Yui, et al.
Publicado: (2019)

Mirabegron for overactive bladder in frail patients 80 years or over (HOKUTO study)
por: Nakagomi, Hiroshi, et al.
Publicado: (2022)

Intermittent restraint stress induces circadian misalignment in the mouse bladder, leading to nocturia
por: Ihara, Tatsuya, et al.
Publicado: (2019)

Author Correction: Intermittent restraint stress induces circadian misalignment in the mouse bladder, leading to nocturia
por: Ihara, Tatsuya, et al.
Publicado: (2019)

Multimodal therapy in the treatment of metastatic prostate cancer: A case report
por: Omidele, Olamide O., et al.
Publicado: (2018)

AMPK Suppresses Connexin43 Expression in the Bladder and Ameliorates Voiding Dysfunction in Cyclophosphamide-induced Mouse Cystitis
por: Zhang, Xiling, et al.
Publicado: (2016)

The oscillation of intracellular Ca(2+) influx associated with the circadian expression of Piezo1 and TRPV4 in the bladder urothelium
por: Ihara, Tatsuya, et al.
Publicado: (2018)

Risk Factors for Atelectasis or Pneumomediastinum After Robot-Assisted Partial Nephrectomy
por: Yano, Fumiakira, et al.
Publicado: (2021)

Pancreatic metastasis from locally recurrent neuroendocrine differentiated prostate cancer after radical prostatectomy
por: Ando, Takashi, et al.
Publicado: (2020)

Female urethral diverticular carcinoma treated by multimodality therapies: A case report
por: Uemura, Koichi, et al.
Publicado: (2018)

Tuberculous Granuloma in the Scrotal Skin After Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: A Case Report
por: Shimura, Hiroshi, et al.
Publicado: (2017)

The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
por: Terry, Stéphane, et al.
Publicado: (2014)

Targeting Neuroendocrine Prostate Cancer: Molecular and Clinical Perspectives
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2015)

Primary neuroendocrine prostate cancer with adrenal gland metastasis
por: Muñoz López, Antonio Yaromin, et al.
Publicado: (2021)

Case report: Adenosquamous carcinoma of the prostate with greater than 20 month response to multimodal therapy
por: Hennessey, Alex, et al.
Publicado: (2019)

Androgen-Targeted Therapy-Induced Epithelial Mesenchymal Plasticity and Neuroendocrine Transdifferentiation in Prostate Cancer: An Opportunity for Intervention
por: Nouri, Mannan, et al.
Publicado: (2014)

A Case of Long-term Survival of Advanced Paratesticular Rhabdomyosarcoma Treated With a Multimodal Therapy Including a Combination of Cyclophosphamide, Vincristine, Doxorubicin and Dacarbazine
por: Isono, Makoto, et al.
Publicado: (2016)

Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?
por: Grigore, Alexandru Dan, et al.
Publicado: (2015)

Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers
por: Soundararajan, Rama, et al.
Publicado: (2018)

Prostate carcinoma with neuroendocrine differentiation successfully treated by early detection with imaging examination
por: Kobayashi, Momoko, et al.
Publicado: (2020)

Neuroendocrine Differentiation in Prostate Cancer: A Mechanism of Radioresistance and Treatment Failure
por: Hu, Chang-Deng, et al.
Publicado: (2015)

Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
por: Wang, Zheng, et al.
Publicado: (2020)

Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation
por: Su, Ruopeng, et al.
Publicado: (2022)

A rare case of prostate neuroendocrine tumor: A case report
por: Teh, Shunxing, et al.
Publicado: (2022)

Two Cases of Primary Spinal Glioblastoma in Adults Treated With Multimodality Therapy
por: Cruz-Lim, Ella Mae, et al.
Publicado: (2022)

Metabolomics analysis of blood identifies potential biomarkers and possible treatment targets for nocturia
por: Kira, Satoru, et al.
Publicado: (2019)

Identification of Novel Diagnosis Biomarkers for Therapy-Related Neuroendocrine Prostate Cancer
por: Zhang, Cuijian, et al.
Publicado: (2021)

Editorial: Nanomaterials and multimodal tumor therapy
por: Yang, Yongqi, et al.
Publicado: (2022)

Multimodal action of ONECUT2 in driving neuroendocrine prostate cancer
por: Kaochar, Salma, et al.
Publicado: (2019)

Angiosarcoma of the Adrenal Gland Treated Using a Multimodal Approach
por: Fuletra, Jay G., et al.
Publicado: (2016)

Co-occurrence of Dermatomyositis and Polycythemia Unveiling Rare de Novo Neuroendocrine Prostate Tumor
por: Papagoras, Charalampos, et al.
Publicado: (2018)

Hypercalcemia due to parathyroid hormone-related peptide secreted by neuroendocrine dedifferentiated prostate cancer
por: Ando, Takashi, et al.
Publicado: (2018)

Treatment-Emergent Neuroendocrine Prostate Cancer: A Clinicopathological and Immunohistochemical Analysis of 94 Cases
por: Zhang, Qingfu, et al.
Publicado: (2021)

A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer
por: Gan, Yu, et al.
Publicado: (2023)

A rare case of de novo large cell neuroendocrine carcinoma of the prostate with long-term survival after cystoprostatectomy and androgen deprivation
por: Miyakawa, Jimpei, et al.
Publicado: (2018)

Analysis of prognostic factors in localized high-risk prostate cancer patients treated with HDR brachytherapy, hypofractionated 3D-CRT and neoadjuvant/adjuvant androgen deprivation therapy (trimodality therapy)
por: Aoki, Manabu, et al.
Publicado: (2014)

Hemorrhagic Renal Angiomyolipoma in Pregnancy Effectively Managed by Immediate Cesarean Section and Elective Transcatheter Arterial Embolization: A Case Report
por: Kira, Satoru, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2pgoneolbq0chgdo591o66a4e8